3.20.2 html 115 309 1 false 29 0 false 7 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 100050 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 100060 - Disclosure - Nature of the Business Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureNatureOfBusiness Nature of the Business Notes 7 false false R8.htm 100070 - Disclosure - Basis of Presentation and Significant Accounting Policies Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPolicies Basis of Presentation and Significant Accounting Policies Notes 8 false false R9.htm 100080 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 9 false false R10.htm 100090 - Disclosure - Property and Equipment Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosurePropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 100100 - Disclosure - Accrued Expenses Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureAccruedExpenses Accrued Expenses Notes 11 false false R12.htm 100110 - Disclosure - Debt Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureDebt Debt Notes 12 false false R13.htm 100120 - Disclosure - Legal and Other Contingencies Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureLegalAndOtherContingencies Legal and Other Contingencies Notes 13 false false R14.htm 100130 - Disclosure - Stockholders' Equity Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 100140 - Disclosure - Stock-Based Compensation Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 15 false false R16.htm 100150 - Disclosure - Marketable Securities Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureMarketableSecurities Marketable Securities Notes 16 false false R17.htm 100160 - Disclosure - Fair Value of Financial Instruments Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 17 false false R18.htm 100170 - Disclosure - Other Expense (Income), Net Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureOtherExpenseIncomeNet Other Expense (Income), Net Notes 18 false false R19.htm 100180 - Disclosure - Net Loss Per Share Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 19 false false R20.htm 100190 - Disclosure - Restructuring Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureRestructuring Restructuring Notes 20 false false R21.htm 100200 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesPolicies Basis of Presentation and Significant Accounting Policies (Policies) Policies http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPolicies 21 false false R22.htm 100210 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssets 22 false false R23.htm 100220 - Disclosure - Property and Equipment (Tables) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) Tables http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosurePropertyAndEquipment 23 false false R24.htm 100230 - Disclosure - Accrued Expenses (Tables) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureAccruedExpenses 24 false false R25.htm 100240 - Disclosure - Debt (Tables) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureDebtTables Debt (Tables) Tables http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureDebt 25 false false R26.htm 100250 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockholdersEquity 26 false false R27.htm 100260 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockBasedCompensation 27 false false R28.htm 100270 - Disclosure - Marketable Securities (Tables) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureMarketableSecuritiesTables Marketable Securities (Tables) Tables http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureMarketableSecurities 28 false false R29.htm 100280 - Disclosure - Other Expense (Income), Net (Tables) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureOtherExpenseIncomeNetTables Other Expense (Income), Net (Tables) Tables http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureOtherExpenseIncomeNet 29 false false R30.htm 100290 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureNetLossPerShare 30 false false R31.htm 100300 - Disclosure - Restructuring (Tables) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureRestructuringTables Restructuring (Tables) Tables http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureRestructuring 31 false false R32.htm 100310 - Disclosure - Nature of the Business - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetail Nature of the Business - Additional Information (Detail) Details 32 false false R33.htm 100320 - Disclosure - Basis of Presentation and Significant Accounting Policies - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesAdditionalInformationDetail Basis of Presentation and Significant Accounting Policies - Additional Information (Detail) Details 33 false false R34.htm 100330 - Disclosure - Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Detail) Details 34 false false R35.htm 100340 - Disclosure - Property and Equipment - Property and Equipment, Net (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentNetDetail Property and Equipment - Property and Equipment, Net (Detail) Details 35 false false R36.htm 100350 - Disclosure - Property and Equipment - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail Property and Equipment - Additional Information (Detail) Details 36 false false R37.htm 100360 - Disclosure - Accrued Expenses - Accrued Expenses (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureAccruedExpensesAccruedExpensesDetail Accrued Expenses - Accrued Expenses (Detail) Details 37 false false R38.htm 100370 - Disclosure - Debt - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetail Debt - Additional Information (Detail) Details 38 false false R39.htm 100380 - Disclosure - Debt - Schedule of Future Principal Payments for Long-Term Debt (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureDebtScheduleOfFuturePrincipalPaymentsForLongTermDebtDetail Debt - Schedule of Future Principal Payments for Long-Term Debt (Detail) Details 39 false false R40.htm 100400 - Disclosure - Stockholder's Equity - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockholderSEquityAdditionalInformationDetail Stockholder's Equity - Additional Information (Detail) Details 40 false false R41.htm 100410 - Disclosure - Stockholder's Equity - Schedule of Transaction Related to Warrants to Purchase Common Stock (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockholderSEquityScheduleOfTransactionRelatedToWarrantsToPurchaseCommonStockDetail Stockholder's Equity - Schedule of Transaction Related to Warrants to Purchase Common Stock (Detail) Details 41 false false R42.htm 100420 - Disclosure - Stock-based Compensation - Transactions Related to Stock Options Awarded to Employees and Directors (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockBasedCompensationTransactionsRelatedToStockOptionsAwardedToEmployeesAndDirectorsDetail Stock-based Compensation - Transactions Related to Stock Options Awarded to Employees and Directors (Detail) Details 42 false false R43.htm 100430 - Disclosure - Stock-based Compensation - Transactions Related to Restricted Stock Units Awarded to Employees (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockBasedCompensationTransactionsRelatedToRestrictedStockUnitsAwardedToEmployeesDetail Stock-based Compensation - Transactions Related to Restricted Stock Units Awarded to Employees (Detail) Details 43 false false R44.htm 100440 - Disclosure - Stock-based Compensation - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail Stock-based Compensation - Additional Information (Detail) Details 44 false false R45.htm 100450 - Disclosure - Stock-based Compensation - Summary of Allocated Stock-based Compensation Expense (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetail Stock-based Compensation - Summary of Allocated Stock-based Compensation Expense (Detail) Details 45 false false R46.htm 100460 - Disclosure - Marketable Securities - Summary of Cash, Cash Equivalents and Marketable Securities (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureMarketableSecuritiesSummaryOfCashCashEquivalentsAndMarketableSecuritiesDetail Marketable Securities - Summary of Cash, Cash Equivalents and Marketable Securities (Detail) Details 46 false false R47.htm 100470 - Disclosure - Marketable Securities - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetail Marketable Securities - Additional Information (Detail) Details 47 false false R48.htm 100480 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail Fair Value of Financial Instruments - Additional Information (Detail) Details 48 false false R49.htm 100490 - Disclosure - Other Expense (Income), Net - Schedule of Other Expense (Income), Net (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureOtherExpenseIncomeNetScheduleOfOtherExpenseIncomeNetDetail Other Expense (Income), Net - Schedule of Other Expense (Income), Net (Detail) Details http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureOtherExpenseIncomeNetTables 49 false false R50.htm 100500 - Disclosure - Net Loss Per Share - Weighted Average Number of Shares Used in Computing Basic and Diluted Net Loss Per Share (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureNetLossPerShareWeightedAverageNumberOfSharesUsedInComputingBasicAndDilutedNetLossPerShareDetail Net Loss Per Share - Weighted Average Number of Shares Used in Computing Basic and Diluted Net Loss Per Share (Detail) Details 50 false false R51.htm 100510 - Disclosure - Net Loss Per Share - Potentially Dilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureNetLossPerSharePotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedWeightedAverageSharesOutstandingDetail Net Loss Per Share - Potentially Dilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail) Details 51 false false R52.htm 100520 - Disclosure - Restructuring - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureRestructuringAdditionalInformationDetail Restructuring - Additional Information (Detail) Details 52 false false R53.htm 100530 - Disclosure - Restructuring - Summary of Accrued Charges and Associated Payments (Detail) Sheet http://www.eloxxpharma.com/20200630/taxonomy/role/DisclosureRestructuringSummaryOfAccruedChargesAndAssociatedPaymentsDetail Restructuring - Summary of Accrued Charges and Associated Payments (Detail) Details 53 false false All Reports Book All Reports elox-10q_20200630.htm elox-20200630.xsd elox-20200630_cal.xml elox-20200630_def.xml elox-20200630_lab.xml elox-20200630_pre.xml elox-ex311_7.htm elox-ex312_9.htm elox-ex321_6.htm elox-ex322_8.htm http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 true true